Abdo J, Ortman H, et al.
The Surgical clinics of North America. Date of publication 2020 Aug 1;volume 100(4):741-756.
1. Surg Clin North Am. 2020 Aug;100(4):741-756. doi: 10.1016/j.suc.2020.05.006.
Epub 2020 Jun 17.
Biologic and Synthetic Cellular and/or Tissue-Based Products and Smart Wound
Dressings/Coverings.
Abdo J(1), Ortman H(2).
Author information:
(1)General Surgery, Marshfield Clinic Health System, 3C1 General Surgery
Residency, 1000 North Oak Avenue, Marshfield, WI 54449, USA.
(2)General Surgery, Marshfield Clinic Health System, 3C1 General Surgery
Residency, 1000 North Oak Avenue, Marshfield, WI 54449, USA. Electronic address:
ortman.holly@marshfieldclinic.org.
Cellular and/or tissue-based products (CTPs) have advanced greatly in the past
several decades and improve the ability to heal wounds more efficiently.
Products can be characterized as nonviable cells, tissue based, animal;
nonviable cells, tissue based, human; viable human cells, cultured in vitro,
animal substrate; viable human cells, cultured in vitro, synthetic substrate;
viable human cells, noncultured, intact tissue. There are approximately 77
different CTPs at the time of this writing, with many more being investigated.
Cellular and/or tissue-based product selection, application, postapplication
course, and patient selection depend on patient attributes, CTP specifications,
and surgeon preference.
Copyright © 2020 Elsevier Inc. All rights reserved.
DOI: 10.1016/j.suc.2020.05.006
PMID: 32681874 [Indexed for MEDLINE]
Conflict of interest statement: Disclosure The authors have nothing to disclose.
